Freshfields Bruckhaus Deringer represented Sumitovant Biopharma Limited.On January 30, 2025, the Second Circuit affirmed the District Court’s dismissal with prejudice of a putative Section 14(a) claim…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
